Evelo Biosciences(EVLO) - 2021 Q4 - Annual Report
Evelo BiosciencesEvelo Biosciences(US:EVLO)2022-03-24 21:17
Transcript

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES For the Fiscal Year Ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38473 Evelo Biosciences, Inc. (Exact name of registrant as specified in its charter) Delaware 2834 46-5594527 (State or other juris ...